[1] Crincoli V, Di Bisceglie MB, Scivetti M, et al. Oral lichen planus: update on etiopathogenesis, diagnosis and treatment [J]. Immunopharmacol Immunotoxicol, 2011, 33(1): 11-20. [2] Xie S, Ding L, Xiong Z, et al. Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus [J]. J Huazhong Univ Sci Technolog Med Sci, 2012, 32(3): 451-457. [3] Haak S, Gyülveszi G, Becher B. Th17 cells in autoimmune disease: changing the verdict [J]. Immunotherapy, 2009, 1(2): 199-203. [4] Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 cells [J]. Annu Rev Immunol, 2009, 27: 485-517. [5] Zheng Y, Valdez PA, Danilenko DM, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens [J]. Nat Med, 2008, 14(3): 282-289. [6] Zhang L, Yang XQ, Cheng J, et al. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity [J]. Clin Immunol, 2010, 135(1): 108-117. [7] Walsh LJ, Ishii T, Savage NW, et al. Immunohistologic analysis of epithelial cell populations in oral lichen planus [J]. J Oral Pathol Med, 1990, 19(4): 177-181. [8] Bag??n-Sebasti??n JV, Mili??n-Masanet MA, Pe?arrocha-Diago M, et al. A clinical study of 205 patients with oral lichen planus [J]. J Oral Maxillofac Surg, 1992, 50(2): 116-118. [9] Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2005, 100(1): 40-51. [10] Hemdan NY, Birkenmeier G, Wichmann G, et al. Interleukin-17-producing T helper cells in autoimmunity [J]. Autoimmun Rev, 2010, 9(11): 785-792. [11] Pène J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes [J]. J Immunol, 2008, 180(11): 7423-7430. [12] Ciprandi G, Filaci G, Battaglia F, et al. Peripheral Th-17 cells in allergic rhinitis: new evidence [J]. Int Immunopharmacol, 2010, 10(2): 226-229. [13] Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self [J]. Nat Immunol, 2005, 6(4): 345-352. [14] Tao XA, Xia J, Chen XB, et al. FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity [J]. Oral Dis, 2010, 16(1): 76-82. [15] Pereira JS, Monteiro BV, Nonaka CF, et al. FoxP3(+) T regulatory cells in oral lichen planus and its correlation with the distinct clinical appearance of the lesions[J]. Int J Exp Pathol,2012,93(4): 287-294. [16] Paradowska A, Masliniski W, Grzybowska-Kowalczyk A, et al. The function of interleukin 17 in the pathogenesis of rheumatoid arthritis [J]. Arch Immunol Ther Exp (Warsz), 2007, 55(5): 329-334. [17] Boissier MC, Assier E, Falgarone G, et al. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm [J]. Joint Bone Spine, 2008, 75(4): 373-375. [18] Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J]. Nature, 2006, 441(7090): 235-238. [19] Shao XS, Yang XQ, Zhao XD, et al. The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome [J]. Pediatr Nephrol, 2009, 24(9): 1683-1690. |